Driving and insulin - Consensus, conflict or confusion?

Authors: Flanagan, D.E.H., Watson, J., Everett, J., Cavan, D. and Kerr, D.

Journal: Diabetic Medicine

Volume: 17

Issue: 4

Pages: 316-320

ISSN: 0742-3071

DOI: 10.1046/j.1464-5491.2000.00279.x

Abstract:

Aims: All drivers requiring insulin treatment must be able to demonstrate satisfactory diabetic control and recognition of hypoglycaemic symptoms before being allowed to drive a motor vehicle. Clinicians have a duty to discuss fitness to drive with their patients. However, is the advice given consistent and in line with the regulations published by the Driver and Vehicle Licensing Authority (DVLA)? Methods: Six 'real-life' case scenarios were posted to clinicians (consultant diabetologists, specialist registrars and diabetes specialist nurses) within Wessex, UK. The identical cases were also sent to the DVLA for their comments. Results: Sixty-six doctors (36 consultants) and 70 diabetes specialist nurses were contacted by postal questionnaire of which replies were received from 17 consultants (47%), 17 specialist registrars (57%) and 39 diabetes specialist nurses (56%). Although there was general agreement in cases of hypoglycaemia unawareness, there was disagreement where patients had or were at risk of unstable control albeit for a short time. Conclusions: Patients treated with insulin may receive conflicting information concerning their ability to drive.

Source: Scopus

Driving and insulin--consensus, conflict or confusion?

Authors: Flanagan, D.E., Watson, J., Everett, J., Cavan, D. and Kerr, D.

Journal: Diabet Med

Volume: 17

Issue: 4

Pages: 316-320

ISSN: 0742-3071

DOI: 10.1046/j.1464-5491.2000.00279.x

Abstract:

AIMS: All drivers requiring insulin treatment must be able to demonstrate satisfactory diabetic control and recognition of hypoglycaemic symptoms before being allowed to drive a motor vehicle. Clinicians have a duty to discuss fitness to drive with their patients. However, is the advice given consistent and in line with the regulations published by the Driver and Vehicle Licensing Authority (DVLA)? METHODS: Six 'real-life' case scenarios were posted to clinicians (consultant diabetologists, specialist registrars and diabetes specialist nurses) within Wessex, UK. The identical cases were also sent to the DVLA for their comments. RESULTS: Sixty-six doctors (36 consultants) and 70 diabetes specialist nurses were contacted by postal questionnaire of which replies were received from 17 consultants (47%), 17 specialist registrars (57%) and 39 diabetes specialist nurses (56%). Although there was general agreement in cases of hypoglycaemia unawareness, there was disagreement where patients had or were at risk of unstable control albeit for a short time. CONCLUSIONS: Patients treated with insulin may receive conflicting information concerning their ability to drive.

Source: PubMed

Driving and insulin - consensus, conflict or confusion?

Authors: Flanagan, D.E.H., Watson, J., Everett, J., Cavan, D. and Kerr, D.

Journal: DIABETIC MEDICINE

Volume: 17

Issue: 4

Pages: 316-320

ISSN: 0742-3071

DOI: 10.1046/j.1464-5491.2000.00279.x

Source: Web of Science (Lite)

Driving and insulin - consensus, conflict or confusion?

Authors: Flanagan, D.E.H., Watson, J.M., Everett, J., Cavan, D.A. and Kerr, D.

Journal: Diabetic Medicine

Volume: 17

Pages: 316-320

ISSN: 0742-3071

DOI: 10.1046/j.1464-5491.2000.00279.x

Abstract:

Aims All drivers requiring insulin treatment must be able to demonstrate satisfactory diabetic control and recognition of hypoglycaemic symptoms before being allowed to drive a motor vehicle. Clinicians have a duty to discuss fitness to drive with their patients. However, is the advice given consistent and in line with the regulations published by the Driver and Vehicle Licensing Authority (DVLA)? Methods Six `real-life' case scenarios were posted to clinicians (consultant diabetologists, specialist registrars and diabetes specialist nurses) within Wessex, UK. The identical cases were also sent to the DVLA for their comments.

Results Sixty-six doctors (36 consultants) and 70 diabetes specialist nurses were contacted by postal questionnaire of which replies were received from 17 consultants (47%), 17 specialist registrars (57%) and 39 diabetes specialist nurses (56%). Although there was general agreement in cases of hypoglycaemia unawareness, there was disagreement where patients had or were at risk of unstable control albeit for a short time.

Conclusions Patients treated with insulin may receive conflicting information concerning their ability to drive.

http://www.blackwell-synergy.com/links/doi/10.1046/j.1464-5491.2000.00279.x

Source: Manual

Preferred by: David Kerr

Driving and insulin--consensus, conflict or confusion?

Authors: Flanagan, D.E., Watson, J., Everett, J., Cavan, D. and Kerr, D.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Volume: 17

Issue: 4

Pages: 316-320

eISSN: 1464-5491

ISSN: 0742-3071

DOI: 10.1046/j.1464-5491.2000.00279.x

Abstract:

Aims

All drivers requiring insulin treatment must be able to demonstrate satisfactory diabetic control and recognition of hypoglycaemic symptoms before being allowed to drive a motor vehicle. Clinicians have a duty to discuss fitness to drive with their patients. However, is the advice given consistent and in line with the regulations published by the Driver and Vehicle Licensing Authority (DVLA)?

Methods

Six 'real-life' case scenarios were posted to clinicians (consultant diabetologists, specialist registrars and diabetes specialist nurses) within Wessex, UK. The identical cases were also sent to the DVLA for their comments.

Results

Sixty-six doctors (36 consultants) and 70 diabetes specialist nurses were contacted by postal questionnaire of which replies were received from 17 consultants (47%), 17 specialist registrars (57%) and 39 diabetes specialist nurses (56%). Although there was general agreement in cases of hypoglycaemia unawareness, there was disagreement where patients had or were at risk of unstable control albeit for a short time.

Conclusions

Patients treated with insulin may receive conflicting information concerning their ability to drive.

Source: Europe PubMed Central